Journal of Clinical Microbiology · 2003 · 52 citations · 15 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceDiagnostic MicrobiologyMedical MicrobiologyAntibiotic ResistanceMycobacterial DiagnosticsTuberculosis CareTuberculosis DiagnosisTuberculosis Diagnostic TestingTuberculosis EpidemiologyDirect DetectionDrug Resistance TestingMolecular Drug ResistanceMolecular Drug Susceptibility TestingMultidrug-resistant OrganismsRapid Molecular DiagnosticsTuberculosis DiagnosticsTuberculosis Drug Resistance
The INNO-LiPA Rif.TB assay is designed for the detection of rpoB gene mutations causing rifampin resistance in isolates. We applied the method directly to 60 Lithuanian and Danish clinical specimens to detect rifampin resistance rapidly. Results were obtained in 78.3% of clinical specimens, and all were concordant with those obtained by BACTEC 460. The assay could have major impact on the management of multidrug-resistant tuberculosis.
15
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
Amalio Telenti, Paul Imboden, Federica Marchesi et al. · The Lancet · 1993 · 1.3K citations
Global Trends in Resistance to Antituberculosis Drugs
Marcos Espinal, A László, Lone Simonsen et al. · New England Journal of Medicine · 2001 · 675 citations
Public Health, Infectious Disease Control, Infectious Diseases +17
Vivek Kapur, L L Li, S Iordănescu et al. · Journal of Clinical Microbiology · 1994 · 316 citations · Full text